Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully...
Main Authors: | Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661823003651 |
Similar Items
-
Impact of klotho on the expression of SRGAP2a in podocytes in diabetic nephropathy
by: Donghua Jin, et al.
Published: (2022-04-01) -
Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
by: Xu He, et al.
Published: (2022-04-01) -
Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease
by: Wei Jiang, et al.
Published: (2023-10-01) -
Hyperhomocysteinemia prevalence among patients with venous thromboembolism
by: R. Ben Salah, et al.
Published: (2024-12-01) -
HYPERHOMOCYSTEINEMIA AND ISCHEMIC STROKE
by: N. V. Pizova, et al.
Published: (2017-05-01)